Abstract

To examine associations between phenotypes of short sleep duration and clinically assessed health conditions in long-term survivors of childhood cancer. Survivorsrecruited from the St. Jude Lifetime Cohort(n=911;52% female;mean age34 years; 26 years postdiagnosis)completedbehavioral health surveysand underwent comprehensive physical examinations. Sleep was assessed with the Pittsburgh Sleep Quality Index. Short sleep was defined as ≤6h per night with phenotypes of short sleep including poor sleep efficiency (<85%), prolonged sleep onset latency (SOL; ≥30 min), and wake after sleep onset (≥3 times per week). Covariates includedchildhood cancertreatment exposures,demographics,body mass index, andphysicalinactivity.Separatemodified Poisson regression modelswere computed foreach healthcategoryto estimaterelative risks (RR)and 95% confidence intervals (CI).Multinomial logistic regression models examined associations between sleep and an aggregated burden of chronic health conditions. Short sleep duration was reported among 44% (95% CI 41%-47%) of survivors. In multivariable models, short sleep duration alone was associated with pulmonary (RR=1.35, 95% CI 1.08-1.69), endocrine (RR=1.22, 95% CI 1.06-1.39) and gastrointestinal/hepatic conditions (RR=1.46, 95% CI 1.18-1.79), and anxiety (RR 3.24, 95% CI 1.64-6.41) and depression (RR=2.33, 95% CI 1.27-4.27). Short sleep with prolonged SOL was associated with a high/severe burden of health conditions (OR=2.35, 95% CI 1.12-4.94). Short sleep duration was associated with multiple clinically ascertained adverse health conditions. Although the temporality of these associations cannot be determined in this cross-sectional study, sleep is modifiable and improving sleep may improve long-term health in survivors.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call